Niazirin

Niazirin
Product Name Niazirin
CAS No.: 122001-32-5
Catalog No.: CFN96998
Molecular Formula: C14H17NO5
Molecular Weight: 279.29 g/mol
Purity: >=98%
Type of Compound: Phenols
Physical Desc.: Powder
Source: The leaves of Moringa oleifera.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price:
The Moringa oleifera extract(including niaziridin and Niazirin) can successfully attenuate the development of pulmonary hypertension via direct vasodilatation and a potential increase in antioxidant activity.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Inflammation.2015, 38(4):1502-16
  • Oncotarget.2017, 9(3):4161-4172
  • J Pharm Biomed Anal.2019, 164:119-127
  • Biomed Pharmacother.2023, 166:115329.
  • J Ethnopharmacol.2017, 206:327-336
  • BMC Complement Med Ther. 2020, 20(1):91.
  • Cell.2022, 185(23):4298-4316.e21.
  • Agriculture2022, 12(12), 2173.
  • Molecules2022, 27(12):3824.
  • Int J Mol Sci.2023, 24(8):7442.
  • 3-Hydroxybenzylamine

    Catalog No: CFN00080
    CAS No: 73604-31-6
    Price: Inquiry(manager@chemfaces.com)
    4-Hydroxybenzylamine

    Catalog No: CFN00081
    CAS No: 696-60-6
    Price: Inquiry(manager@chemfaces.com)
    Niazinin

    Catalog No: CFN89344
    CAS No: 147821-57-6
    Price: Inquiry(manager@chemfaces.com)
    Niazimicin

    Catalog No: CFN89363
    CAS No: 147821-49-6
    Price: Inquiry(manager@chemfaces.com)
    Niazirin

    Catalog No: CFN96998
    CAS No: 122001-32-5
    Price: Inquiry(manager@chemfaces.com)
    Moringin

    Catalog No: CFN89445
    CAS No: 73255-40-0
    Price: Inquiry(manager@chemfaces.com)
    4-Hydroxybenzamide

    Catalog No: CFN97063
    CAS No: 619-57-8
    Price: $30/20mg
    Benzamide

    Catalog No: CFN98925
    CAS No: 55-21-0
    Price: Inquiry(manager@chemfaces.com)
    Obtucarbamate A

    Catalog No: CFN96025
    CAS No: 6935-99-5
    Price: $238/20mg
    Obtucarbamate B

    Catalog No: CFN96026
    CAS No: 20913-18-2
    Price: $318/10mg
    Mutat Res. 1999 Apr 6;440(2):181-8.
    An antitumor promoter from Moringa oleifera Lam.[Pubmed: 10209341]
    In the course of studies on the isolation of bioactive compounds from Philippine plants, the seeds of Moringa oleifera Lam. were examined and from the ethanol extract were isolated the new O-ethyl-4-(alpha-L-rhamnosyloxy)benzyl carbamate (1) together with seven known compounds, 4(alpha-L-rhamnosyloxy)-benzyl isothiocyanate (2), niazimicin (3), Niazirin (4), beta-sitosterol (5), glycerol-1-(9-octadecanoate) (6), 3-O-(6'-O-oleoyl-beta-D-glucopyranosyl)-beta-sitosterol (7), and beta-sitosterol-3-O-beta-D-glucopyranoside (8).
    METHODS AND RESULTS:
    Four of the isolates (2, 3, 7, and 8), which were obtained in relatively good yields, were tested for their potential antitumor promoting activity using an in vitro assay which tested their inhibitory effects on Epstein-Barr virus-early antigen (EBV-EA) activation in Raji cells induced by the tumor promoter, 12-O-tetradecanoyl-phorbol-13-acetate (TPA). All the tested compounds showed inhibitory activity against EBV-EA activation, with compounds 2, 3 and 8 having shown very significant activities. Based on the in vitro results, niazimicin (3) was further subjected to in vivo test and found to have potent antitumor promoting activity in the two-stage carcinogenesis in mouse skin using 7,12-dimethylbenz(a)anthracene (DMBA) as initiator and TPA as tumor promoter.
    CONCLUSIONS:
    From these results, niazimicin (3) is proposed to be a potent chemo-preventive agent in chemical carcinogenesis.
    Chin J Physiol. 2012 Apr 30;55(2):101-7.
    Effects of 2-azafluorenones on phosphatidyl-inositol specific phospholipase C activation in c6 glioma cells.[Pubmed: 22559734 ]
    The purpose of this study was to determine the effects of an extract from Moringa oleifera (MO) on the development of monocrotaline (MCT)-induced pulmonary hypertension (PH) in Wistar rats. An ethanol extraction was performed on dried MO leaves, and HPLC analysis identified niaziridin and Niazirin in the extract.
    METHODS AND RESULTS:
    PH was induced with a single subcutaneous injection of MCT (60 mg/kg) which resulted in increases in pulmonary arterial blood pressure (Ppa) and in thickening of the pulmonary arterial medial layer in the rats. Three weeks after induction, acute administration of the MO extract to the rats decreased Ppa in a dose-dependent manner that reached statistical significance at a dose of 4.5 mg of freeze-dried extract per kg body weight. The reduction in Ppa suggested that the extract directly relaxed the pulmonary arteries. To assay the effects of chronic administration of the MO extract on PH, control, MCT and MCT+MO groups were designated. Rats in the control group received a saline injection; the MCT and MCT+MO groups received MCT to induce PH. During the third week after MCT treatment, the MCT+MO group received daily i.p. injections of the MO extract (4.5 mg of freeze-dried extract/kg of body weight). Compared to the control group, the MCT group had higher Ppa and thicker medial layers in the pulmonary arteries. Chronic treatments with the MO extract reversed the MCT-induced changes. Additionally, the MCT group had a significant elevation in superoxide dismutase activity when normalized by the MO extract treatments.
    CONCLUSIONS:
    In conclusion, the MO extract successfully attenuated the development of PH via direct vasodilatation and a potential increase in antioxidant activity.
    Carasiphenol C

    Catalog No: CFN95045
    CAS No: 868168-04-1
    Price: $368/5mg
    Physalin O

    Catalog No: CFN95097
    CAS No: 120849-18-5
    Price: $413/5mg
    New Compound 1

    Catalog No: CFN95152
    CAS No: N/A
    Price: $398/5mg
    1,7-Diphenyl-5-hydroxy-4,6-hepten-3-one

    Catalog No: CFN95171
    CAS No: 87095-77-0
    Price: $318/10mg
    [(1(10)E,2R,4R)]-2-Methoxy-8,12-epoxygemacra-1(10),7,11-trien-6-one

    Catalog No: CFN95198
    CAS No: 75412-95-2
    Price: $318/10mg
    Bruceantinol B

    Catalog No: CFN95216
    CAS No: 1822332-33-1
    Price: $318/5mg
    Perlolyrine

    Catalog No: CFN95291
    CAS No: 29700-20-7
    Price: $413/5mg
    13(S)-Hydroxyoctadeca-9(Z),11(E)-dienoic acid (13-HODE)

    Catalog No: CFN95307
    CAS No: 18104-45-5
    Price: $318/10mg
    New compound 15

    Catalog No: CFN95413
    CAS No: N/A
    Price: $413/5mg
    Moreollic acid

    Catalog No: CFN95437
    CAS No: 173792-68-2
    Price: $318/5mg